{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:29:41Z","timestamp":1791210581727,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T00:00:00Z","timestamp":1379030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11892-013-0431-7","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T21:33:57Z","timestamp":1378935237000},"page":"757-767","source":"Crossref","is-referenced-by-count":30,"title":["What the Genetics of Lipodystrophy Can Teach Us About Insulin Resistance and Diabetes"],"prefix":"10.1007","volume":"13","author":[{"given":"Camille","family":"Vatier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bidault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Briand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Gu\u00e9nantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Teyssi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,13]]},"reference":[{"key":"431_CR1","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","volume":"96","author":"A Garg","year":"2011","unstructured":"Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96:3313\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.biocel.2011.03.002","volume":"43","author":"C Vigouroux","year":"2011","unstructured":"Vigouroux C, Caron-Debarle M, Le Dour C, Magr\u00e9 J, Capeau J. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol. 2011;43:862\u201376.","journal-title":"Int J Biochem Cell Biol"},{"key":"431_CR3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","volume":"402","author":"I Barroso","year":"1999","unstructured":"Barroso I, Gurnell M, Crowley VE, et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 1999;402:880\u20133.","journal-title":"Nature"},{"key":"431_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","volume":"9","author":"H Cao","year":"2000","unstructured":"Cao H, Hegele RA. Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000;9:109\u201312.","journal-title":"Hum Mol Genet"},{"key":"431_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","volume":"24","author":"S Shackleton","year":"2000","unstructured":"Shackleton S, Lloyd DJ, Jackson SN, et al. LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24:153\u20136.","journal-title":"Nat Genet"},{"key":"431_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","volume":"28","author":"J Magr\u00e9","year":"2001","unstructured":"Magr\u00e9 J, Del\u00e9pine M, Khallouf E, et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nature Genet. 2001;28:365\u201370.","journal-title":"Nature Genet"},{"key":"431_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","volume":"31","author":"AK Agarwal","year":"2002","unstructured":"Agarwal AK, Arioglu E, De Almeida S, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 2002;31:21\u20133.","journal-title":"Nat Genet"},{"key":"431_CR8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","volume":"304","author":"S George","year":"2004","unstructured":"George S, Rochford JJ, Wolfrum C, et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004;304:1325\u20138.","journal-title":"Science"},{"key":"431_CR9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","volume":"93","author":"C Kim","year":"2008","unstructured":"Kim C, Del\u00e9pine M, Boutet E, et al. Association of a homozygous nonsense Caveolin-1 mutation with Berardinelli-Seip Congenital Lipodystrophy. J Clin Endocrinol Metab. 2008;93:1129\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","volume":"1","author":"O Rubio-Cabezas","year":"2009","unstructured":"Rubio-Cabezas O, Puri V, Murano I, et al. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med. 2009;1:280\u20137.","journal-title":"EMBO Mol Med."},{"key":"431_CR11","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","volume":"119","author":"YK Hayashi","year":"2009","unstructured":"Hayashi YK, Matsuda C, Ogawa M, et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest. 2009;119:2623\u201333.","journal-title":"J Clin Invest"},{"key":"431_CR12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","volume":"364","author":"S Gandotra","year":"2011","unstructured":"\u2022\u2022 Gandotra S, Le Dour C, Bottomley W, et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med. 2011;364:740\u20138. Each of these studies (references 3\u201312) identified genes involved in lipodystrophic syndromes, underlying the importance of a primary defect in adipose tissue for metabolism at the systemic level.","journal-title":"N Engl J Med"},{"key":"431_CR13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","volume":"71","author":"G Novelli","year":"2002","unstructured":"Novelli G, Muchir A, Sangiuolo F, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C. Am J Hum Genet. 2002;71:426\u201331.","journal-title":"Am J Hum Genet"},{"key":"431_CR14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","volume":"300","author":"A Sandre-Giovannoli De","year":"2003","unstructured":"De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin A truncation in Hutchinson-Gilford progeria. Science. 2003;300:2055.","journal-title":"Science"},{"key":"431_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","volume":"423","author":"M Eriksson","year":"2003","unstructured":"Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423:293\u20138.","journal-title":"Nature"},{"key":"431_CR16","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","volume":"12","author":"AK Agarwal","year":"2003","unstructured":"Agarwal AK, Fryns JP, Auchus RJ, Garg A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet. 2003;12:1995\u20132001.","journal-title":"Hum Mol Genet"},{"key":"431_CR17","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","volume":"14","author":"M Caron","year":"2007","unstructured":"Caron M, Auclair M, Donadille B, et al. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress, and premature cellular senescence. Cell Death Differ. 2007;14:1759\u201367.","journal-title":"Cell Death Differ"},{"key":"431_CR18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","volume":"87","author":"AK Agarwal","year":"2010","unstructured":"\u2022\u2022 Agarwal AK, Xing C, DeMartino GN, et al. PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet. 2010;87:866\u201372. This work reported the identification of PSMB8 as the gene involved in JMP syndrome, showing that autoinflammation can lead to lipodystrophy.","journal-title":"Am J Hum Genet"},{"key":"431_CR19","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1172\/JCI58414","volume":"121","author":"A Kitamura","year":"2011","unstructured":"Kitamura A, Maekawa Y, Uehara H, et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest. 2011;121:4150\u201360.","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"431_CR20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/sj.ijo.0801267","volume":"24","author":"G Ailhaud","year":"2000","unstructured":"Ailhaud G. Adipose tissue as an endocrine organ. Int J Obes Relat Metab Disord. 2000;24 Suppl 2:S1\u20133.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"431_CR21","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.biochi.2012.06.026","volume":"94","author":"JP Bastard","year":"2012","unstructured":"Bastard JP, F\u00e8ve B. The secretory face of the adipose cell: a tribute to two queens, leptin and adiponectin. Biochimie. 2012;94:2063\u20134.","journal-title":"Biochimie"},{"key":"431_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1467-789X.2003.00091.x","volume":"4","author":"GH Goossens","year":"2003","unstructured":"Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev. 2003;4:43\u201355.","journal-title":"Obes Rev"},{"key":"431_CR23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF03185938","volume":"65","author":"S Caspar-Bauguil","year":"2009","unstructured":"Caspar-Bauguil S, Cousin B, Bour S, et al. Adipose tissue lymphocytes: types and roles. J Physiol Biochem. 2009;65:423\u201336.","journal-title":"J Physiol Biochem"},{"key":"431_CR24","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71:2455\u201365.","journal-title":"Cancer Res"},{"key":"431_CR25","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","volume":"12","author":"I Shimomura","year":"1998","unstructured":"Shimomura I, Hammer RE, Richardson JA, et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 1998;12:3182\u201394.","journal-title":"Genes Dev"},{"key":"431_CR26","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1101\/gad.12.20.3168","volume":"12","author":"J Moitra","year":"1998","unstructured":"Moitra J, Mason MM, Olive M, et al. Life without white fat: a transgenic mouse. Genes Dev. 1998;12:3168\u201381.","journal-title":"Genes Dev"},{"key":"431_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","volume":"105","author":"O Gavrilova","year":"2000","unstructured":"Gavrilova O, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest. 2000;105:271\u20138.","journal-title":"J Clin Invest"},{"key":"431_CR28","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2337\/diabetes.51.9.2727","volume":"51","author":"C Colombo","year":"2002","unstructured":"Colombo C, Cutson JJ, Yamauchi T, et al. Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy. Diabetes. 2002;51:2727\u201333.","journal-title":"Diabetes"},{"key":"431_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","volume":"401","author":"I Shimomura","year":"1999","unstructured":"Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999;401:73\u20136.","journal-title":"Nature"},{"key":"431_CR30","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","volume":"350","author":"A Garg","year":"2004","unstructured":"Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350:1220\u201334.","journal-title":"N Engl J Med"},{"key":"431_CR31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1651-2227.1996.tb14262.x","volume":"413","author":"M Seip","year":"1996","unstructured":"Seip M, Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl. 1996;413:2\u201328.","journal-title":"Acta Paediatr Suppl"},{"key":"431_CR32","first-page":"33","volume":"43","author":"MG Dunnigan","year":"1974","unstructured":"Dunnigan MG, Cochrane MA, Kelly A, Scott JW. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q J Med. 1974;43:33\u201348.","journal-title":"Q J Med"},{"key":"431_CR33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/jc.84.1.170","volume":"84","author":"A Garg","year":"1999","unstructured":"Garg A, Peshock RM, Fleckenstein JL. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab. 1999;84:170\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR34","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","volume":"96","author":"MC Vantyghem","year":"2008","unstructured":"Vantyghem MC, Vincent-Desplanques D, Defrance-Faivre F, et al. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. J Clin Endocrinol Metab. 2008;96:2223\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR35","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jc.87.5.2395","volume":"87","author":"WA Haque","year":"2002","unstructured":"Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002;87:2395\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jc.2009-1824","volume":"95","author":"B Antuna-Puente","year":"2010","unstructured":"Antuna-Puente B, Boutet E, Vigouroux C, et al. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency. J Clin Endocrinol Metab. 2010;95:1463\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR37","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2337\/dc07-0025","volume":"30","author":"CM Valerio","year":"2007","unstructured":"Valerio CM, Godoy-Matos A, Moreira RO, et al. Dual-energy X-ray absorptiometry study of body composition in patients with lipodystrophy. Diabetes Care. 2007;30:1857\u20139.","journal-title":"Diabetes Care"},{"key":"431_CR38","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0022-2275(20)40090-2","volume":"35","author":"N Abate","year":"1994","unstructured":"Abate N, Burns D, Peshock RM, Garg A, Grundy SM. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res. 1994;35:1490\u20136.","journal-title":"J Lipid Res"},{"key":"431_CR39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-69-3-501","volume":"69","author":"JD Brunzell","year":"1968","unstructured":"Brunzell JD, Shankle SW, Bethune JE. Congenital generalized lipodystrophy accompanied by cystic angiomatosis. Ann Intern Med. 1968;69:501\u201316.","journal-title":"Ann Intern Med"},{"key":"431_CR40","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","volume":"92","author":"A Decaudain","year":"2007","unstructured":"Decaudain A, Vantyghem MC, Guerci B, et al. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab. 2007;92:4835\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","volume":"32","author":"RK Semple","year":"2011","unstructured":"Semple RK, Savage DB, Cochran EK, Gorden P, O\u2019Rahilly S. Genetic syndromes of severe insulin resistance. Endocr Rev. 2011;32:498\u2013514.","journal-title":"Endocr Rev"},{"key":"431_CR42","first-page":"315","volume":"119","author":"RK Semple","year":"2009","unstructured":"Semple RK, Sleigh A, Murgatroyd PR, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009;119:315\u201322.","journal-title":"J Clin Invest"},{"key":"431_CR43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","volume":"93","author":"C Thauvin-Robinet","year":"2013","unstructured":"Thauvin-Robinet C, Auclair M, Duplomb L, et al. Mutations in PIK3R1 cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet. 2013;93:141\u20139.","journal-title":"Am J Hum Genet"},{"key":"431_CR44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","volume":"39","author":"L Maldergem Van","year":"2002","unstructured":"Van Maldergem L, Magr\u00e9 J, Gedde-Dahl Jr T, et al. Genotype-phenotype relationships in berardinelli-seip congenital lipodystrophy. J Med Genet. 2002;39:722\u201333.","journal-title":"J Med Genet"},{"key":"431_CR45","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","volume":"88","author":"V Simha","year":"2003","unstructured":"Simha V, Garg A. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or Seipin genes. J Clin Endocrinol Metab. 2003;88:5433\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MOL.0b013e328354fcf4","volume":"23","author":"AK Agarwal","year":"2012","unstructured":"\u2022 Agarwal AK. Lysophospholipid acyltransferases: 1-acylglycerol-3-phosphate O-acyltransferases. From discovery to disease. Curr Opin Lipidol. 2012;23:290\u2013302. A comprehensive review about the role of AGPAT isoforms.","journal-title":"Curr Opin Lipidol"},{"key":"431_CR47","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.2337\/db12-0004","volume":"61","author":"AR Subauste","year":"2012","unstructured":"Subauste AR, Das AK, Li X, et al. Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes. 2012;61:2922\u201331.","journal-title":"Diabetes"},{"key":"431_CR48","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1194\/jlr.R023754","volume":"53","author":"BR Cartwright","year":"2012","unstructured":"\u2022 Cartwright BR, Goodman JM. Seipin: from human disease to molecular mechanism. J Lipid Res. 2012;53:1042\u201355. A recent complete review on the role of seipin, in particular in lipid droplet assembly and maintenance and in adipocyte differentiation.","journal-title":"J Lipid Res"},{"key":"431_CR49","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","volume":"104","author":"KM Szymanski","year":"2007","unstructured":"Szymanski KM, Binns D, Bartz R, et al. The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc Natl Acad Sci U S A. 2007;104:20890\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"431_CR50","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.biochi.2009.01.011","volume":"91","author":"E Boutet","year":"2009","unstructured":"Boutet E, El Mourabit H, Prot M, et al. Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy. Biochimie. 2009;91:796\u2013803.","journal-title":"Biochimie"},{"key":"431_CR51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ceb.2012.05.012","volume":"24","author":"H Yang","year":"2012","unstructured":"\u2022 Yang H, Galea A, Sytnyk V, Crossley M. Controlling the size of lipid droplets: lipid and protein factors. Curr Opin Cell Biol. 2012;24:509\u201316. A comprehensive review about the structure of lipid droplets and the mechanisms involved in their assembly and growth.","journal-title":"Curr Opin Cell Biol"},{"key":"431_CR52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/brain\/awn216","volume":"132","author":"D Ito","year":"2009","unstructured":"Ito D, Suzuki N. Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain. 2009;132:8\u201315.","journal-title":"Brain"},{"key":"431_CR53","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/hmg\/dds523","volume":"22","author":"M Holtta-Vuori","year":"2013","unstructured":"Holtta-Vuori M, Salo VT, Ohsaki Y, Suster ML, Ikonen E. Alleviation of seipinopathy-related ER stress by triglyceride storage. Hum Mol Genet. 2013;22:1157\u201366.","journal-title":"Hum Mol Genet"},{"key":"431_CR54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-7-3","volume":"7","author":"H Cao","year":"2008","unstructured":"Cao H, Alston L, Ruschman J, Hegele RA. Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids Health Dis. 2008;7:3.","journal-title":"Lipids Health Dis"},{"key":"431_CR55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.152.5.1071","volume":"152","author":"AG Ostermeyer","year":"2001","unstructured":"Ostermeyer AG, Paci JM, Zeng Y, et al. Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets. J Cell Biol. 2001;152:1071\u20138.","journal-title":"J Cell Biol"},{"key":"431_CR56","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1083\/jcb.152.5.1057","volume":"152","author":"A Pol","year":"2001","unstructured":"Pol A, Luetterforst R, Lindsay M, et al. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J Cell Biol. 2001;152:1057\u201370.","journal-title":"J Cell Biol"},{"key":"431_CR57","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4161\/auto.6.6.12574","volume":"6","author":"S Lay Le","year":"2010","unstructured":"\u2022 Le Lay S, Briand N, Blouin CM, et al. The lipoatrophic caveolin-1 deficient mouse model reveals autophagy in mature adipocytes. Autophagy. 2010;6:754\u201363. Autophagy, a new pathway involved in lipodystrophy in caveolin-1 deficient mice.","journal-title":"Autophagy"},{"key":"431_CR58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1194\/jlr.M001016","volume":"51","author":"CM Blouin","year":"2010","unstructured":"Blouin CM, Le Lay S, Eberl A, et al. Lipid droplet analysis in caveolin-deficient adipocytes: alterations in surface phospholipid composition and maturation defects. J Lipid Res. 2010;51:945\u201356.","journal-title":"J Lipid Res"},{"key":"431_CR59","doi-asserted-by":"crossref","first-page":"e1000874","DOI":"10.1371\/journal.pgen.1000874","volume":"6","author":"A Rajab","year":"2010","unstructured":"Rajab A, Straub V, McCann LJ, et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet. 2010;6:e1000874.","journal-title":"PLoS Genet"},{"key":"431_CR60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cell.2007.11.042","volume":"132","author":"MM Hill","year":"2008","unstructured":"Hill MM, Bastiani M, Luetterforst R, et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008;132:113\u201324.","journal-title":"Cell"},{"key":"431_CR61","doi-asserted-by":"crossref","first-page":"E856","DOI":"10.1210\/jc.2010-2234","volume":"96","author":"C Dour Le","year":"2011","unstructured":"Le Dour C, Schneebeli S, Bakiri F, et al. A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A. J Clin Endocrinol Metab. 2011;96:E856\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nmd.2012.11.011","volume":"23","author":"KM Wiltshire","year":"2013","unstructured":"Wiltshire KM, Hegele RA, Innes AM, Brownell AK. Homozygous lamin A\/C familial lipodystrophy R482Q mutation in autosomal recessive Emery Dreifuss muscular dystrophy. Neuromuscul Disord. 2013;23:265\u20138.","journal-title":"Neuromuscul Disord"},{"key":"431_CR63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.2999","volume":"226","author":"HJ Worman","year":"2012","unstructured":"Worman HJ. Nuclear lamins and laminopathies. J Pathol. 2012;226:316\u201325.","journal-title":"J Pathol"},{"key":"431_CR64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrm3488","volume":"14","author":"B Burke","year":"2013","unstructured":"Burke B, Stewart CL. The nuclear lamins: flexibility in function. Nat Rev Mol Cell Biol. 2013;14:13\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"431_CR65","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","volume":"49","author":"C Vigouroux","year":"2000","unstructured":"Vigouroux C, Magr\u00e9 J, Vantyghem MC, et al. Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes. 2000;49:1958\u201362.","journal-title":"Diabetes"},{"key":"431_CR66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2003-38388","volume":"35","author":"D Ara\u00fajo-Vilar","year":"2003","unstructured":"Ara\u00fajo-Vilar D, Loidi L, Dom\u00ednguez F, Cabezas-Cerrato J. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A\/C R482W mutation. Horm Metab Res. 2003;35:29\u201335.","journal-title":"Horm Metab Res"},{"key":"431_CR67","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ajpath.2011.07.049","volume":"179","author":"V B\u00e9r\u00e9ziat","year":"2011","unstructured":"\u2022 B\u00e9r\u00e9ziat V, Cervera P, Le Dour C, et al. LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue. Am J Pathol. 2011;179:2443\u201353. This work reported that accumulated adipose tissue in familial partial lipodystrophy is dystrophic, showing fibrosis and an altered differentiation pattern with brown fat-like adipocytes.","journal-title":"Am J Pathol"},{"key":"431_CR68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-12-0268","volume":"167","author":"PB Mory","year":"2012","unstructured":"Mory PB, Crispim F, Freire MB, et al. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations. Eur J Endocrinol. 2012;167:423\u201331.","journal-title":"Eur J Endocrinol"},{"key":"431_CR69","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","volume":"88","author":"F Caux","year":"2003","unstructured":"Caux F, Dubosclard E, Lascols O, et al. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab. 2003;88:1006\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR70","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1210\/jc.2009-0472","volume":"94","author":"A Garg","year":"2009","unstructured":"Garg A, Subramanyam L, Agarwal AK, et al. Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J Clin Endocrinol Metab. 2009;94:4971\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR71","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/hmg\/ddi158","volume":"14","author":"C Capanni","year":"2005","unstructured":"Capanni C, Mattioli E, Columbaro M, et al. Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Hum Mol Genet. 2005;14:1489\u2013502.","journal-title":"Hum Mol Genet"},{"key":"431_CR72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09879","volume":"472","author":"GH Liu","year":"2011","unstructured":"\u2022\u2022 Liu GH, Barkho BZ, Ruiz S, et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature. 2011;472:221\u20135. These 2 studies highlighted the role of progerin (prelamin A mutated in Hutchinson-Gilford progeria) in ageing-associated cell phenotypes during differentiation and showed that iPSC are a model for studying the pathogenesis of laminopathies.","journal-title":"Nature"},{"key":"431_CR73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2010.12.002","volume":"8","author":"J Zhang","year":"2011","unstructured":"\u2022\u2022 Zhang J, Lian Q, Zhu G, et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell. 2011;8:31\u201345. These 2 studies highlighted the role of progerin (prelamin A mutated in Hutchinson-Gilford progeria) in ageing-associated cell phenotypes during differentiation and showed that iPSC are a model for studying the pathogenesis of laminopathies.","journal-title":"Cell Stem Cell"},{"key":"431_CR74","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ncb1708","volume":"10","author":"P Scaffidi","year":"2008","unstructured":"Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol. 2008;10:452\u20139.","journal-title":"Nat Cell Biol"},{"key":"431_CR75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-7580.2008.00928.x","volume":"213","author":"V Pekovic","year":"2008","unstructured":"Pekovic V, Hutchison CJ. Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches. J Anat. 2008;213:5\u201325.","journal-title":"J Anat"},{"key":"431_CR76","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4161\/cc.8.10.8499","volume":"8","author":"N Naetar","year":"2009","unstructured":"Naetar N, Foisner R. Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis. Cell Cycle. 2009;8:1488\u201393.","journal-title":"Cell Cycle"},{"key":"431_CR77","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","volume":"77","author":"P Tontonoz","year":"2008","unstructured":"Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289\u2013312.","journal-title":"Annu Rev Biochem"},{"key":"431_CR78","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tem.2009.04.005","volume":"20","author":"EH Jeninga","year":"2009","unstructured":"Jeninga EH, Gurnell M, Kalkhoven E. Functional implications of genetic variation in human PPARgamma. Trends Endocrinol Metab. 2009;20:380\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"431_CR79","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/ATVBAHA.112.300962","volume":"33","author":"M Auclair","year":"2013","unstructured":"\u2022 Auclair M, Vigouroux C, Boccara F, et al. Peroxisome proliferator-activated receptor-gamma mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system. Arterioscler Thrombos Vasc Biol. 2013;33:829\u201338. A translational study of peroxisome proliferator-activated receptor \u03b3 translational study of peroxisome proliferator-activated rsupporting a role for PPAR\u03b3 as a regulator of blood pressure through its ability to modulate the cellular renin-angiotensin system.","journal-title":"Arterioscler Thrombos Vasc Biol."},{"key":"431_CR80","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1111\/j.1742-4658.2010.07806.x","volume":"277","author":"F Li","year":"2010","unstructured":"Li F, Gu Y, Dong W, et al. Cell death-inducing DFF45-like effector, a lipid droplet-associated protein, might be involved in the differentiation of human adipocytes. FEBS J. 2010;277:4173\u201383.","journal-title":"FEBS J"},{"key":"431_CR81","doi-asserted-by":"crossref","first-page":"34998","DOI":"10.1074\/jbc.M111.278853","volume":"286","author":"S Gandotra","year":"2011","unstructured":"Gandotra S, Lim K, Girousse A, et al. Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5). J Biol Chem. 2011;286:34998\u20135006.","journal-title":"J Biol Chem"},{"key":"431_CR82","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/505885","volume":"79","author":"RA Hegele","year":"2006","unstructured":"Hegele RA, Cao H, Liu DM, et al. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am J Hum Genet. 2006;79:383\u20139.","journal-title":"Am J Hum Genet"},{"key":"431_CR83","first-page":"375","volume":"25","author":"J Gao","year":"2012","unstructured":"Gao J, Li Y, Fu X, Luo X. A Chinese patient with acquired partial lipodystrophy caused by a novel mutation with LMNB2 gene. J Pediatr Endocrinol Metab. 2012;25:375\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"431_CR84","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.0704212104","volume":"104","author":"C Coffinier","year":"2007","unstructured":"Coffinier C, Hudon SE, Farber EA, et al. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc Natl Acad Sci U S A. 2007;104:13432\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"431_CR85","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","volume":"109","author":"LB Gordon","year":"2012","unstructured":"\u2022\u2022 Gordon LB, Kleinman ME, Miller DT, et al. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2012;109:16666\u201371. Results from the first clinical trial with farnesyl-transferase inhibitor in Hutchinson-Gilford progeria syndrome, showing the improvement of vascular stiffness and bone structure.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"431_CR86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1750-1172-8-106","volume":"8","author":"B Donadille","year":"2013","unstructured":"Donadille B, D\u2019Anella P, Auclair M, et al. Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome. Orphanet J Rare Dis. 2013;8:106.","journal-title":"Orphanet J Rare Dis."},{"key":"431_CR87","doi-asserted-by":"crossref","unstructured":"Weedon MN, Ellard S, Prindle MJ, et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet. 2013; [In press].","DOI":"10.1038\/ng.2670"},{"key":"431_CR88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0190-9622(96)90673-8","volume":"35","author":"PR Dahl","year":"1996","unstructured":"Dahl PR, Zalla MJ, Winkelmann RK. Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol. 1996;35:523\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"431_CR89","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2009.286","volume":"34","author":"KN Manolopoulos","year":"2010","unstructured":"Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes. 2010;34:949\u201359.","journal-title":"Int J Obes"},{"key":"431_CR90","first-page":"338","volume":"2010","author":"S Virtue","year":"1801","unstructured":"Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2013an allostatic perspective. Biochim Biophys Acta. 1801;2010:338\u201349.","journal-title":"Biochim Biophys Acta"},{"key":"431_CR91","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/jcem-57-3-517","volume":"57","author":"DE Wilson","year":"1983","unstructured":"Wilson DE, Chan IF, Stevenson KB, Horton SC, Schipke C. Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance. J Clin Endocrinol Metab. 1983;57:517\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.med.57.022605.114424","volume":"57","author":"AK Agarwal","year":"2006","unstructured":"Agarwal AK, Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med. 2006;57:297\u2013311.","journal-title":"Annu Rev Med"},{"key":"431_CR93","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","volume":"346","author":"EA Oral","year":"2002","unstructured":"Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570\u20138.","journal-title":"N Engl J Med"},{"key":"431_CR94","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/jc.87.7.3110","volume":"87","author":"EA Oral","year":"2002","unstructured":"Oral EA, Ruiz E, Andewelt A, et al. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab. 2002;87:3110\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR95","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","volume":"54","author":"ED Javor","year":"2005","unstructured":"Javor ED, Cochran EK, Musso C, et al. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes. 2005;54:1994\u20132002.","journal-title":"Diabetes"},{"key":"431_CR96","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","volume":"92","author":"K Ebihara","year":"2007","unstructured":"Ebihara K, Kusakabe T, Hirata M, et al. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab. 2007;92:532\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR97","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s00125-004-1570-9","volume":"47","author":"X Yu","year":"2004","unstructured":"Yu X, McCorkle S, Wang M, et al. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia. 2004;47:2012\u201321.","journal-title":"Diabetologia"},{"key":"431_CR98","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941\u20136.","journal-title":"Nat Med"},{"key":"431_CR99","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bjps.2011.02.009","volume":"64","author":"DR Calderoni","year":"2011","unstructured":"Calderoni DR, Ramos TM, de Castro JR, Kharmandayan P. Surgical management of phenotypic alterations related to the Dunnigan variety of familial partial lipodystrophy. J Plast Reconstr Aesthet Surg. 2011;64:1248\u201350.","journal-title":"J Plast Reconstr Aesthet Surg"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-013-0431-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-013-0431-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-013-0431-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T21:25:10Z","timestamp":1646515510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-013-0431-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,13]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1007\/s11892-013-0431-7","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,13]]}}}